| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Department of Laboratory Medicine, Yale New Haven Hospital, and Yale University School of Medicine, New Haven, Connecticut
Received 28 September 2007/ Returned for modification 5 December 2007/ Accepted 20 December 2007
A Light Diagnostics human metapneumovirus (HMPV) monoclonal antibody reagent was evaluated using cytospin-enhanced direct immunofluorescence (DFA), and the results were compared to those for TaqMan reverse transcription-PCR (RT-PCR). Of the 202 samples tested, 48 were positive by RT-PCR, and 41 (85.4%) of these were positive by DFA (P = 0.0771). The commercial availability of an HMPV DFA reagent will be of significant benefit to clinical laboratories.
Published ahead of print on 9 January 2008.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|